Astragaloside IV Alleviates Renal Tubular Epithelial-Mesenchymal Transition via CX3CL1-RAF/MEK/ERK Signaling Pathway in Diabetic Kidney Disease

Astragaloside IV Alleviates Renal Tubular Epithelial-Mesenchymal Transition via CX3CL1-RAF/MEK/ERK Signaling Pathway in Diabetic Kidney Disease

Yonghui Hu,1,2,* Wangna Tang,1,2,* Wenjie Liu,1,2 Zhibo Hu,1,2 Congqing Pan1,2 1NHC Key Laboratory of Hormones and Development, Tianjin Key Laboratory of Metabolic Diseases, Chu Hsien-I Memorial Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, P...

Full description

Bibliographic Details
Main Authors: Hu Y, Tang W, Liu W, Hu Z, Pan C
Format: Article
Language:English
Published: Dove Medical Press 2022-05-01
Series:Drug Design, Development and Therapy
Subjects:
astragaloside iv
epithelial-mesenchymal transition
cx3cl1
diabetic kidney disease
renal fibrosis
Online Access:https://www.dovepress.com/astragaloside-iv-alleviates-renal-tubular-epithelial-mesenchymal-trans-peer-reviewed-fulltext-article-DDDT

Internet

https://www.dovepress.com/astragaloside-iv-alleviates-renal-tubular-epithelial-mesenchymal-trans-peer-reviewed-fulltext-article-DDDT

Similar Items